Skip to main content
NOVAREX Co., Ltd. logo

NOVAREX Co., Ltd. — Investor Relations & Filings

Ticker · 194700 ISIN · KR7194700001 KO Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2025-03-14 Major Shareholding Noti…
Country KR South Korea
Listing KO 194700

About NOVAREX Co., Ltd.

https://www.novarex.co.kr/en/

NOVAREX Co., Ltd. is a research and development-driven company specializing in health functional foods and supplements. It operates as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM), offering end-to-end services that encompass product planning, development, manufacturing, and delivery. Through its Life Science Research Center, the company develops novel functional ingredients validated by thorough verification and human application testing. NOVAREX manufactures a diverse range of product formulations, including tablets, capsules, powders, and stick jellies. A key competitive advantage is its extensive portfolio of individually recognized raw materials, underscoring its focus on scientific innovation and quality.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as collateral) of major shareholders and their special related parties. This falls under the category of 'Major Shareholding Notification' (MRQ).
2025-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Novarex Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, dividend approval, director appointments), and detailed management information regarding board activities, audit reports, and business overviews. This document is a standard proxy statement and meeting notice provided to shareholders to inform them of the upcoming AGM and solicit their votes. In the context of financial filings, this is classified as a Proxy Solicitation & Information Statement.
2025-03-11 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Novarex regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Novarex. It outlines the date, location, agenda items (such as financial statement approval, dividend approval, and director appointments), and board resolution details. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of Proxy Solicitation & Information Statement.
2025-03-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal notification filed by Novarex regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict due to audit timelines and accounting requirements. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results of the meeting, it falls under the general regulatory filing category.
2025-03-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2025-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.